Launching of Mela B3 La Roche-Posay
As a result of 18 years of research in pigmentation science, La Roche-Posay has introduced the new MELA B3 product range featuring L’Oréal’s biggest pigmentation innovation, MelasylTM.
First presented at the World Congress of Dermatology 2023, MelasylTM was unveiled alongside the results of a first-of-its-kind health-related study involving 48,000 participants from 34 countries across all continents. The study revealed a high prevalence of pigmentation disorders worldwide and a significant impact on quality of life and stigmatization.
Priscilla Wong graced the event
The MELA B3 product lineup highlights a new era in hyperpigmentation treatment, addressing a widespread skin concern that affects millions globally and profoundly impacts both appearance and mental well-being.
Key benefits of the MELA B3 include anti-inflammation properties to reduce inflammation caused by UV exposure and pollution, skin renewal, and exfoliation to promote cellular turnover and diminish dark spots, and antioxidant protection to shield against free radicals that stimulate melanin production. These features together are expected to deliver visible results in just one week.
Mela B3 range products
As an effort to help raise awareness of hyperpigmentation in general, Dr. Ch’ng Chin Chwen, a Dermatologist consultant from the Subang Jaya Medical Centre, made a special appearance and shared the various causes and effects of hyperpigmentation along with preventive measures. Through her sharing, visitors were able to understand what was needed for their skin, and also be debunked on the myths of hyperpigmentation.
The MELA B3 range is available at all leading pharmacies and e-commerce platforms. MELA B3 Clarifying Micro-Peeling Gel Cleanser RM 89.90, MELA B3 Serum RM 199.90, MELA B3 Cream SPF 30 RM 159.90.For additional information about La Roche-Posay, visit www.laroche-posay.com.
